全文获取类型
收费全文 | 275篇 |
免费 | 1篇 |
专业分类
电工技术 | 2篇 |
化学工业 | 2篇 |
机械仪表 | 1篇 |
轻工业 | 1篇 |
石油天然气 | 2篇 |
冶金工业 | 267篇 |
自动化技术 | 1篇 |
出版年
2016年 | 1篇 |
2010年 | 1篇 |
2008年 | 2篇 |
1999年 | 4篇 |
1998年 | 63篇 |
1997年 | 40篇 |
1996年 | 38篇 |
1995年 | 17篇 |
1994年 | 18篇 |
1993年 | 18篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 1篇 |
1985年 | 4篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1978年 | 1篇 |
1977年 | 7篇 |
1976年 | 31篇 |
排序方式: 共有276条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
Enhancement of DNA vaccine immunogenicity is a current topic of high priority in the field of applied immunology, especially as a means of controlling HIV infection. The adjuvant effect of Ubenimex (UBX), an anti-cancer immunomodulator, on a DNA AIDS vaccine which we developed was examined in a murine model. UBX was formulated into a preparation containing DNA plasmids encoding env and rev genes of HIV-1 strain III(B), and was inoculated intramuscularly into BALB/c mice. The sera obtained with this mixture had 2(3)-2(5) times higher specific IgG titres than those obtained without the use of the adjuvant. UBX also elicited both a stronger HIV-1-specific DTH reaction, as measured by the footpad swelling test, and stronger cytotoxic T lymphocyte activity, as assayed by the 51Cr-release method, compared with responses using DNA alone. The cytokine secretion profile of restimulated immune lymphoid cells showed that UBX raised IL-2 and interferon-gamma levels and decreased IL-4 production. HIV-1-specific immunoglobulin subtype analysis demonstrated that UBX stimulated IgG2a production but suppressed synthesis of IgG1 and IgE. These results indicate that activation of the T-helper type 1 subset was induced by UBX, suggesting a mechanism of immunomodulation mediated by this agent. We conclude that UBX acts as an immunologic adjuvant for DNA vaccination against HIV-1. UBX may be a suitable adjuvant for clinical use because of its lack of antigenicity and low toxicity. 相似文献
45.
46.
47.
48.
49.
DJ Pettibone BV Clineschmidt MT Kishel EV Lis DR Reiss CJ Woyden BE Evans RM Freidinger DF Veber MJ Cook 《Canadian Metallurgical Quarterly》1993,264(1):308-314
L-366,509, a member of a novel class of nonpeptidyl compounds, has been characterized as an orally active oxytocin (OT) antagonist. L-366,509 exhibits a moderate binding affinity (K(i) values, 370-780 nM) for the rat, rhesus and human uterine OT receptor. L-366,509 also binds to vasopressin receptor subtypes (arginine vasopressin-V1 and V2) with measurable affinity in rat (K(i) values, 25-30 microM) and primate (K(i) values, 2-6 microM) tissues. In rat uterine slices, L-366,509 inhibits (IC50 = 1.6 microM) the stimulation of phosphatidylinositol turnover induced by OT but not bradykinin. In the rat isolated uterus, L-366,509 is a competitive and reversible OT antagonist (pA2 = 7.32). In vivo, L-366,509 given i.v. (10 mg/kg) or intraduodenally (10-50 mg/kg) to rats causes a marked and long-lasting inhibition of OT-stimulated uterine activity. OT antagonist activity in a pregnant rhesus macaque (approximately day 135 gestation) is also observed with L-366,509 after i.v. or p.o. dosing. L-366,509 represents a prototype for a new chemical class of OT antagonists with significant p.o. bioavailability. 相似文献
50.
An algorithm that identifies the connnected components of a thresholded digitized picture is presented. The time complexity of the algorithm is linear in the number of runs of object pixels in the picture. 相似文献